38 Results | Everything | Search

Product TypeClear Filters

Analytical Chemistry (5)

Biochemicals (38)

Small Molecule Modulators (37)

Research AreaClear Filters

Cancer (38)

Angiogenesis (3)

Cell Cycle (2)

Cell Death (10)

Cell Migration & Metastasis (3)

Cell Signaling (38)

Abl family & Bcr-Abl Signaling (38)

Aurora Signaling (3)

ERK/MAPK Signaling (4)

Growth Factor Receptor Signaling (16)

Hedgehog Signaling (1)

JAK/STAT Signaling (2)

PI3K/Akt/mTOR Signaling (1)

SRC Family Signaling (14)

Multidrug Resistance (6)

Transcription Factors (1)

Cardiovascular System (3)

Cell Biology (7)

Endocrinology & Metabolism (1)

Immunology & Inflammation (8)

Infectious Disease (7)

Neuroscience (4)

Xenobiotic Metabolism (2)

ApplicationClear Filters

Mass Spectrometry (5)

Displaying 1 - 25 of 38 Results

Imatinib (mesylate)

An inhibitor of c-Abl, Bcr-Abl, PDGFR, and c-Kit

CAS No. 220127-57-1

Item No. 13139

Formulation: A crystalline solid

Purity: ≥98%

CGP57148B
STI-571

25 mg

$38

Add

50 mg

$72

Add

100 mg

$97

Add

500 mg

$449

Add

Dasatinib

An inhibitor of Abl and Src

CAS No. 302962-49-8

Item No. 11498

Formulation: A crystalline solid

Purity: ≥98%

BMS 354825
Sprycel

10 mg

$36

Add

50 mg

$53

Add

100 mg

$88

Add

250 mg

$176

Add

Nilotinib

A Bcr-Abl inhibitor

CAS No. 641571-10-0

Item No. 10010422

Formulation: A crystalline solid

Purity: ≥95%

AMN107

5 mg

$28

Add

10 mg

$41

Add

25 mg

$81

Add

50 mg

$130

Add

Ponatinib

An inhibitor of native and mutant Bcr-Abl

CAS No. 943319-70-8

Item No. 11494

Formulation: A crystalline solid

Purity: ≥98%

AP 24534

1 mg

$32

Add

5 mg

$86

Add

10 mg

$109

Add

Bosutinib

An inhibitor of Src and Abl kinases

CAS No. 380843-75-4

Item No. 12030

Formulation: A crystalline solid

Purity: ≥98%

SKI 606

5 mg

$49

Add

10 mg

$73

Add

50 mg

$283

Add

100 mg

$469

Add

Saracatinib

A dual inhibitor of c-Src and Abl

CAS No. 379231-04-6

Item No. 11497

Formulation: A crystalline solid

Purity: ≥90%

AZD 0530

5 mg

$35

Add

10 mg

$59

Add

25 mg

$119

Add

50 mg

$168

Add

PD 166326

An inhibitor of c-src and certain receptor tyrosine kinases, including c-abl

CAS No. 185039-91-2

Item No. 9000988

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$108

Add

5 mg

$481

Add

10 mg

$856

Add

AT-9283

A broad spectrum kinase inhibitor

CAS No. 896466-04-9

Item No. 11496

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$98

Add

10 mg

$176

Add

25 mg

$318

Add

50 mg

$490

Add

Nilotinib-d₆

An internal standard for the quantification of nilotinib

CAS No. 1268356-17-7

Item No. 19280

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₆)

1 mg

$569

Add

N-desmethyl Imatinib

A major active metabolite of imatinib

CAS No. 404844-02-6

Item No. 16947

Formulation: A lyophilized solid

Purity: ≥95%

N-desmethyl Gleevec
STI-509-00

500 µg

$42

Add

1 mg

$79

Add

5 mg

$303

Add

10 mg

$561

Add

AST-487

A multi-kinase inhibitor

CAS No. 630124-46-8

Item No. 19477

Formulation: A crystalline solid

Purity: ≥98%

NVP-AST-487

1 mg

$37

Add

5 mg

$124

Add

10 mg

$229

Add

25 mg

$523

Add

Asciminib

An allosteric inhibitor of Abl1

CAS No. 1492952-76-7

Item No. 26126

Formulation: A crystalline solid

Purity: ≥95%

ABL001

1 mg

$69

Add

5 mg

$280

Add

10 mg

$525

Add

ALW-II-41-27

A multi-kinase inhibitor

CAS No. 1186206-79-0

Item No. 25275

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$69

Add

5 mg

$297

Add

10 mg

$525

Add

Imatinib-d₃

An internal standard for the quantification of imatinib

CAS No. 1134803-18-1

Item No. 18257

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

Genfatinib-d₃

500 µg

$112

Add

1 mg

$202

Add

GZD-824

A Bcr/Abl inhibitor

CAS No. 1257628-77-5

Item No. 21508

Formulation: A crystalline solid

Purity: ≥98%

HQP1351
Olverembatinib

1 mg

$36

Add

5 mg

$153

Add

10 mg

$268

Add

25 mg

$502

Add

Ponatinib-d₈

An internal standard for the quantification of ponatinib

CAS No. 1562993-37-6

Item No. 28905

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₈)

1 mg

$390

Add

Radotinib

A selective Bcr-Abl tyrosine kinase inhibitor

CAS No. 926037-48-1

Item No. 19923

Formulation: A crystalline solid

Purity: ≥98%

IY-5511

1 mg

$36

Add

5 mg

$120

Add

10 mg

$203

Add

25 mg

$378

Add

MGCD-265

A c-Met and VEGFR2 inhibitor

CAS No. 875337-44-3

Item No. 20097

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$48

Add

5 mg

$190

Add

10 mg

$355

Add

25 mg

$708

Add

Bafetinib

A Bcr-Abl inhibitor

CAS No. 859212-16-1

Item No. 19169

Formulation: A crystalline solid

Purity: ≥95%

INNO-406
NS-187

1 mg

$49

Add

5 mg

$130

Add

10 mg

$236

Add

KW 2449

A multi-kinase inhibitor

CAS No. 1000669-72-6

Item No. 22207

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$36

Add

10 mg

$64

Add

25 mg

$150

Add

50 mg

$264

Add

Rebastinib

An orally bioavailable tyrosine kinase inhibitor

CAS No. 1020172-07-9

Item No. 21465

Formulation: A crystalline solid

Purity: ≥98%

DCC-2036

1 mg

$52

Add

5 mg

$227

Add

10 mg

$396

Add

25 mg

$867

Add

NG 25 (hydrochloride hydrate)

An inhibitor of MAP4K2 and TAK1

Item No. 27579

Formulation: A solid

Purity: ≥98%

1 mg

$60

Add

5 mg

$185

Add

10 mg

$339

Add

XL228

A tyrosine kinase inhibitor

CAS No. 898280-07-4

Item No. 21506

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$90

Add

10 mg

$158

Add

25 mg

$354

Add

50 mg

$634

Add

Ponatinib (hydrochloride)

An inhibitor of native and mutant Bcr-Abl

CAS No. 1114544-31-8

Item No. 35778

Formulation: A solid

Purity: ≥98%

AP 24534

50 mg

$46

Add

100 mg

$85

Add

500 mg

$357

Add

1 g

$579

Add

Bosutinib-d₈

An internal standard for the quantification of bosutinib

CAS No. 2733145-45-2

Item No. 25460

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₈)

500 µg

$160

Add

1 mg

$304

Add

Displaying 1 - 25 of 38 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥90%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d6)

Formulation: A lyophilized solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d8)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d8)

Purity: ≥99% deuterated forms (d₁-d₆)

Purity: ≥99% deuterated forms (d₁-d₃)

Purity: ≥99% deuterated forms (d₁-d₈)

Purity: ≥99% deuterated forms (d₁-d₈)